KR101582910B1 - 스핑고신 포스페이트 수용체의 신규한 모듈레이터 - Google Patents
스핑고신 포스페이트 수용체의 신규한 모듈레이터 Download PDFInfo
- Publication number
- KR101582910B1 KR101582910B1 KR1020107028062A KR20107028062A KR101582910B1 KR 101582910 B1 KR101582910 B1 KR 101582910B1 KR 1020107028062 A KR1020107028062 A KR 1020107028062A KR 20107028062 A KR20107028062 A KR 20107028062A KR 101582910 B1 KR101582910 B1 KR 101582910B1
- Authority
- KR
- South Korea
- Prior art keywords
- delete delete
- compound
- heteroaryl
- alkyl
- heterocyclyl
- Prior art date
Links
- 0 BN(*)C(CC)(*C)C(C)=O Chemical compound BN(*)C(CC)(*C)C(C)=O 0.000 description 7
- KTJOGYGCAHFVMW-UHFFFAOYSA-N CCN(CC)CCN(CC1)c2c1c(-c1n[o]c(-c(cc3)cc(OCC)c3OCC)n1)ccc2 Chemical compound CCN(CC)CCN(CC1)c2c1c(-c1n[o]c(-c(cc3)cc(OCC)c3OCC)n1)ccc2 KTJOGYGCAHFVMW-UHFFFAOYSA-N 0.000 description 2
- UJLHXAYGCPWCFD-UHFFFAOYSA-N C1Oc(cc(cc2)-c3nc(-c4ccncc4)n[o]3)c2O1 Chemical compound C1Oc(cc(cc2)-c3nc(-c4ccncc4)n[o]3)c2O1 UJLHXAYGCPWCFD-UHFFFAOYSA-N 0.000 description 1
- UDZRDIFQJWEYAM-UHFFFAOYSA-N CC(C)COc(cc1)ccc1-c1nc(-c2ccncc2)n[o]1 Chemical compound CC(C)COc(cc1)ccc1-c1nc(-c2ccncc2)n[o]1 UDZRDIFQJWEYAM-UHFFFAOYSA-N 0.000 description 1
- BJSVUUUXVSJMIW-UHFFFAOYSA-N CC(C)Oc(c(C#N)c1)ccc1-c1ncc(-c2c(CCC3O)c3ccc2)[o]1 Chemical compound CC(C)Oc(c(C#N)c1)ccc1-c1ncc(-c2c(CCC3O)c3ccc2)[o]1 BJSVUUUXVSJMIW-UHFFFAOYSA-N 0.000 description 1
- ASEJWCIBBAVTCL-UHFFFAOYSA-N CCCOc(cc1)ccc1-c1nc(-c2ccncc2)n[o]1 Chemical compound CCCOc(cc1)ccc1-c1nc(-c2ccncc2)n[o]1 ASEJWCIBBAVTCL-UHFFFAOYSA-N 0.000 description 1
- HULJYUIYIUQRCW-UHFFFAOYSA-N CCN(CC)CCNC1c2cccc(-c3n[o]c(-c(cc4OCC)ccc4OCC)n3)c2CC1 Chemical compound CCN(CC)CCNC1c2cccc(-c3n[o]c(-c(cc4OCC)ccc4OCC)n3)c2CC1 HULJYUIYIUQRCW-UHFFFAOYSA-N 0.000 description 1
- HDQOGGVPUVKQKB-ORDCHZPPSA-N CCO/C(/C(/OCC)=C\C(Cc1nc(-c2c(C)cncc2)n[o]1)=C)=C/C Chemical compound CCO/C(/C(/OCC)=C\C(Cc1nc(-c2c(C)cncc2)n[o]1)=C)=C/C HDQOGGVPUVKQKB-ORDCHZPPSA-N 0.000 description 1
- KCXBTYIFXBRQMO-UHFFFAOYSA-N CCOC1C(OCC)=CC(c2nc(-c3cccc4c3c(CNC)c[nH]4)n[o]2)=CC1C Chemical compound CCOC1C(OCC)=CC(c2nc(-c3cccc4c3c(CNC)c[nH]4)n[o]2)=CC1C KCXBTYIFXBRQMO-UHFFFAOYSA-N 0.000 description 1
- MXXFMRYMQWTRGW-UHFFFAOYSA-N CCOc(c(OCC)c1)ccc1-c1nc(-c2c(CCC3N(C)C)c3ccc2)n[o]1 Chemical compound CCOc(c(OCC)c1)ccc1-c1nc(-c2c(CCC3N(C)C)c3ccc2)n[o]1 MXXFMRYMQWTRGW-UHFFFAOYSA-N 0.000 description 1
- NUIKTBLZSPQGCP-UHFFFAOYSA-N CCOc(c(OCC)c1)ccc1-c1nc(-c2c(CCC3NCCO)c3ccc2)n[o]1 Chemical compound CCOc(c(OCC)c1)ccc1-c1nc(-c2c(CCC3NCCO)c3ccc2)n[o]1 NUIKTBLZSPQGCP-UHFFFAOYSA-N 0.000 description 1
- BJICXXWDWJHTON-UHFFFAOYSA-N CCOc(c(OCC)c1)ccc1-c1nc(-c2ccc3[nH]cc(CNCCN(C)C)c3c2)n[o]1 Chemical compound CCOc(c(OCC)c1)ccc1-c1nc(-c2ccc3[nH]cc(CNCCN(C)C)c3c2)n[o]1 BJICXXWDWJHTON-UHFFFAOYSA-N 0.000 description 1
- PHTHPSFVPAIWBY-UHFFFAOYSA-N CCOc(c(OCC)c1)ccc1-c1nc(-c2ccc3[nH]cc(CNCCO)c3c2)n[o]1 Chemical compound CCOc(c(OCC)c1)ccc1-c1nc(-c2ccc3[nH]cc(CNCCO)c3c2)n[o]1 PHTHPSFVPAIWBY-UHFFFAOYSA-N 0.000 description 1
- LNWZTEMYQBBIDH-UHFFFAOYSA-N CCOc(c(OCC)c1)ccc1-c1nnc(-c2ccncc2)[nH]1 Chemical compound CCOc(c(OCC)c1)ccc1-c1nnc(-c2ccncc2)[nH]1 LNWZTEMYQBBIDH-UHFFFAOYSA-N 0.000 description 1
- MVKJCEWLSYXEGL-UHFFFAOYSA-N CCOc(ccc(-c1nc(-c(cc2)cc3c2[nH]cc3CN(C)CCO)n[o]1)c1)c1OCC Chemical compound CCOc(ccc(-c1nc(-c(cc2)cc3c2[nH]cc3CN(C)CCO)n[o]1)c1)c1OCC MVKJCEWLSYXEGL-UHFFFAOYSA-N 0.000 description 1
- RFNAOFFZMHTEFM-UHFFFAOYSA-N CCOc(ccc(-c1nc(-c2c(CCC3O)c3ccc2)n[o]1)c1)c1OCC Chemical compound CCOc(ccc(-c1nc(-c2c(CCC3O)c3ccc2)n[o]1)c1)c1OCC RFNAOFFZMHTEFM-UHFFFAOYSA-N 0.000 description 1
- SMIOXIHYDYWMNU-UHFFFAOYSA-N CCOc(ccc(-c1nc(-c2c(c(CN(CC3)CC3O)c[nH]3)c3ccc2)n[o]1)c1)c1OCC Chemical compound CCOc(ccc(-c1nc(-c2c(c(CN(CC3)CC3O)c[nH]3)c3ccc2)n[o]1)c1)c1OCC SMIOXIHYDYWMNU-UHFFFAOYSA-N 0.000 description 1
- PWOIEFATGIUPIC-UHFFFAOYSA-N CCOc(ccc(-c1nc(-c2cc(CN3CCCC3)ncc2)n[o]1)c1)c1OCC Chemical compound CCOc(ccc(-c1nc(-c2cc(CN3CCCC3)ncc2)n[o]1)c1)c1OCC PWOIEFATGIUPIC-UHFFFAOYSA-N 0.000 description 1
- QSVMZGILVZFPSL-UHFFFAOYSA-N CCOc(ccc(-c1nc(-c2cc(NCC3)c3cc2)n[o]1)c1)c1OCC Chemical compound CCOc(ccc(-c1nc(-c2cc(NCC3)c3cc2)n[o]1)c1)c1OCC QSVMZGILVZFPSL-UHFFFAOYSA-N 0.000 description 1
- YCTCKIKAZRTXRV-UHFFFAOYSA-N CCOc(ccc(-c1nc(-c2ccc(CCO)cc2)n[o]1)c1)c1[O](C)CC Chemical compound CCOc(ccc(-c1nc(-c2ccc(CCO)cc2)n[o]1)c1)c1[O](C)CC YCTCKIKAZRTXRV-UHFFFAOYSA-N 0.000 description 1
- OWAZJYIXSGYPLQ-UHFFFAOYSA-N CCOc(ccc(-c1nc(-c2cccc3c2CCN3CCO)n[o]1)c1)c1OCC Chemical compound CCOc(ccc(-c1nc(-c2cccc3c2CCN3CCO)n[o]1)c1)c1OCC OWAZJYIXSGYPLQ-UHFFFAOYSA-N 0.000 description 1
- MMKXHTDCKLZHIM-UHFFFAOYSA-N CCOc(ccc(-c1nc(-c2ccncc2)n[o]1)c1)c1OCC Chemical compound CCOc(ccc(-c1nc(-c2ccncc2)n[o]1)c1)c1OCC MMKXHTDCKLZHIM-UHFFFAOYSA-N 0.000 description 1
- XXYGZRCRYXALIX-ZQRQZVKFSA-N CCOc(ccc(-c1nc(C2=CCC3NC=C(CN(CC4)C[C@H]4O)C3=C2)n[o]1)c1)c1OCC Chemical compound CCOc(ccc(-c1nc(C2=CCC3NC=C(CN(CC4)C[C@H]4O)C3=C2)n[o]1)c1)c1OCC XXYGZRCRYXALIX-ZQRQZVKFSA-N 0.000 description 1
- UCIDXHXWKSCMMA-UHFFFAOYSA-N CCOc(ccc(-c1nnc(-c2ccncc2)[o]1)c1)c1OCC Chemical compound CCOc(ccc(-c1nnc(-c2ccncc2)[o]1)c1)c1OCC UCIDXHXWKSCMMA-UHFFFAOYSA-N 0.000 description 1
- YPYLYOORMPBHLX-UHFFFAOYSA-O CCOc(ccc(/C(/O)=N/C(c1c(CCC2NCCO)c2ccc1)=[NH2+])c1)c1OCC Chemical compound CCOc(ccc(/C(/O)=N/C(c1c(CCC2NCCO)c2ccc1)=[NH2+])c1)c1OCC YPYLYOORMPBHLX-UHFFFAOYSA-O 0.000 description 1
- MMMNKIGRGCUFCC-UHFFFAOYSA-N CCOc1cc(-c2ncc(-c3ccncc3)[o]2)ccc1OC Chemical compound CCOc1cc(-c2ncc(-c3ccncc3)[o]2)ccc1OC MMMNKIGRGCUFCC-UHFFFAOYSA-N 0.000 description 1
- HYAWBYQHPIAONU-UHFFFAOYSA-N CC[O](C)c1cc(-c2nc(-c3ccncc3)n[o]2)ccc1OC Chemical compound CC[O](C)c1cc(-c2nc(-c3ccncc3)n[o]2)ccc1OC HYAWBYQHPIAONU-UHFFFAOYSA-N 0.000 description 1
- QFVLKNVMGIZJPZ-UHFFFAOYSA-N COc(c(-c1nc(-c2ccncc2)n[o]1)c1)cc(OC)c1OC Chemical compound COc(c(-c1nc(-c2ccncc2)n[o]1)c1)cc(OC)c1OC QFVLKNVMGIZJPZ-UHFFFAOYSA-N 0.000 description 1
- VTLMFXPYCLVBNY-UHFFFAOYSA-N COc(cc1)ccc1-c1nc(-c2ccncc2)n[o]1 Chemical compound COc(cc1)ccc1-c1nc(-c2ccncc2)n[o]1 VTLMFXPYCLVBNY-UHFFFAOYSA-N 0.000 description 1
- ISCFIAKKHACAIY-UHFFFAOYSA-N Cc(ccc(-c1ncc(-c2c(CCC3NCCO)c3ccc2)[o]1)c1)c1C#N Chemical compound Cc(ccc(-c1ncc(-c2c(CCC3NCCO)c3ccc2)[o]1)c1)c1C#N ISCFIAKKHACAIY-UHFFFAOYSA-N 0.000 description 1
- FVVXWRGARUACNW-UHFFFAOYSA-N Cc1cc2ccccc2cn1 Chemical compound Cc1cc2ccccc2cn1 FVVXWRGARUACNW-UHFFFAOYSA-N 0.000 description 1
- XEJQXKPZLXQORW-UHFFFAOYSA-N FC(c(cc1)ccc1-c1n[o]c(-c2cnccc2)n1)(F)F Chemical compound FC(c(cc1)ccc1-c1n[o]c(-c2cnccc2)n1)(F)F XEJQXKPZLXQORW-UHFFFAOYSA-N 0.000 description 1
- BLMBPQPECPEUOQ-UHFFFAOYSA-N NS(c(cc1)ccc1-c1n[o]c(-c(cc2)cc(C(F)(F)F)c2-c2ccccc2)n1)(=O)=O Chemical compound NS(c(cc1)ccc1-c1n[o]c(-c(cc2)cc(C(F)(F)F)c2-c2ccccc2)n1)(=O)=O BLMBPQPECPEUOQ-UHFFFAOYSA-N 0.000 description 1
- QOMGENKRSYTFMM-UHFFFAOYSA-N NS(c(cc1)ccc1-c1n[o]c(-c2ccc(C3CCCCC3)cc2)n1)(=O)=O Chemical compound NS(c(cc1)ccc1-c1n[o]c(-c2ccc(C3CCCCC3)cc2)n1)(=O)=O QOMGENKRSYTFMM-UHFFFAOYSA-N 0.000 description 1
- OEIZIUFGNJNCHR-UHFFFAOYSA-O [NH2+]=C(c1ccc(CCO)cc1)/N=C(/c1cc(-c2ccccc2)c(C(F)(F)F)[s]1)\O Chemical compound [NH2+]=C(c1ccc(CCO)cc1)/N=C(/c1cc(-c2ccccc2)c(C(F)(F)F)[s]1)\O OEIZIUFGNJNCHR-UHFFFAOYSA-O 0.000 description 1
Images
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Health & Medical Sciences (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12760308P | 2008-05-14 | 2008-05-14 | |
US61/127,603 | 2008-05-14 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020157013971A Division KR20150064245A (ko) | 2008-05-14 | 2009-05-14 | 스핑고신 포스페이트 수용체의 신규한 모듈레이터 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110010777A KR20110010777A (ko) | 2011-02-07 |
KR101582910B1 true KR101582910B1 (ko) | 2016-01-08 |
Family
ID=43426295
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020107028062A KR101582910B1 (ko) | 2008-05-14 | 2009-05-14 | 스핑고신 포스페이트 수용체의 신규한 모듈레이터 |
KR1020157013971A KR20150064245A (ko) | 2008-05-14 | 2009-05-14 | 스핑고신 포스페이트 수용체의 신규한 모듈레이터 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020157013971A KR20150064245A (ko) | 2008-05-14 | 2009-05-14 | 스핑고신 포스페이트 수용체의 신규한 모듈레이터 |
Country Status (12)
Country | Link |
---|---|
KR (2) | KR101582910B1 (es) |
CN (1) | CN102118972B (es) |
BR (1) | BRPI0912545B1 (es) |
CA (1) | CA2723904C (es) |
DK (1) | DK2913326T3 (es) |
HR (1) | HRP20201316T1 (es) |
HU (1) | HUE050411T2 (es) |
IL (1) | IL209306A (es) |
LT (1) | LT2913326T (es) |
MX (1) | MX2010012461A (es) |
SI (1) | SI2913326T1 (es) |
ZA (1) | ZA201007804B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA021672B1 (ru) | 2008-05-14 | 2015-08-31 | Дзе Скриппс Рисёч Инститьют | Модуляторы рецепторов сфингозин-1-фосфата и их применение |
JP6615876B2 (ja) * | 2014-06-26 | 2019-12-04 | モナシュ ユニヴァーシティ | 酵素相互作用薬剤 |
US11111223B2 (en) | 2016-06-14 | 2021-09-07 | Receptos Llc | Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereof |
WO2018033149A1 (zh) * | 2016-08-19 | 2018-02-22 | 苏州科睿思制药有限公司 | 奥扎莫德的晶型及其制备方法 |
WO2018049632A1 (zh) | 2016-09-14 | 2018-03-22 | 杭州领业医药科技有限公司 | 奥扎莫德的晶型、其制备方法及药物组合物 |
CN109640982A (zh) | 2016-09-14 | 2019-04-16 | 苏州科睿思制药有限公司 | 奥扎莫德盐酸盐的晶型及其制备方法 |
CN106749213B (zh) * | 2016-11-25 | 2019-07-02 | 济南大学 | 一种具有1,2,4-恶二唑结构的吲哚衍生物及制备方法和在制备抗菌药物中的应用 |
US11117876B2 (en) | 2017-08-31 | 2021-09-14 | Receptos Llc | Crystalline form of ozanimod hydrochloride, and processes for preparation thereof |
CN107827837B (zh) * | 2017-11-21 | 2021-09-24 | 苏州朗科生物技术股份有限公司 | 鞘氨醇-1-磷酸受体调节剂化合物及其制备方法与应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007116866A1 (ja) | 2006-04-03 | 2007-10-18 | Astellas Pharma Inc. | ヘテロ化合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4516430B2 (ja) * | 2002-12-20 | 2010-08-04 | メルク・シャープ・エンド・ドーム・コーポレイション | 1−(アミノ)インダン並びに(1,2−ジヒドロ−3−アミノ)−ベンゾフラン、ベンゾチオフェン及びインドール |
-
2009
- 2009-05-14 KR KR1020107028062A patent/KR101582910B1/ko active IP Right Grant
- 2009-05-14 LT LTEP15158887.8T patent/LT2913326T/lt unknown
- 2009-05-14 CA CA2723904A patent/CA2723904C/en active Active
- 2009-05-14 BR BRPI0912545-0A patent/BRPI0912545B1/pt active IP Right Grant
- 2009-05-14 CN CN200980127478.8A patent/CN102118972B/zh active Active
- 2009-05-14 KR KR1020157013971A patent/KR20150064245A/ko not_active Application Discontinuation
- 2009-05-14 HU HUE15158887A patent/HUE050411T2/hu unknown
- 2009-05-14 DK DK15158887.8T patent/DK2913326T3/da active
- 2009-05-14 SI SI200932087T patent/SI2913326T1/sl unknown
- 2009-05-14 MX MX2010012461A patent/MX2010012461A/es active IP Right Grant
-
2010
- 2010-11-01 ZA ZA2010/07804A patent/ZA201007804B/en unknown
- 2010-11-14 IL IL209306A patent/IL209306A/en active Protection Beyond IP Right Term
-
2020
- 2020-08-24 HR HRP20201316TT patent/HRP20201316T1/hr unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007116866A1 (ja) | 2006-04-03 | 2007-10-18 | Astellas Pharma Inc. | ヘテロ化合物 |
Also Published As
Publication number | Publication date |
---|---|
CA2723904C (en) | 2017-03-14 |
DK2913326T3 (da) | 2020-08-17 |
IL209306A (en) | 2017-02-28 |
CA2723904A1 (en) | 2009-12-17 |
ZA201007804B (en) | 2012-01-25 |
LT2913326T (lt) | 2020-09-10 |
IL209306A0 (en) | 2011-01-31 |
BRPI0912545B1 (pt) | 2022-02-01 |
KR20150064245A (ko) | 2015-06-10 |
MX2010012461A (es) | 2013-07-02 |
KR20110010777A (ko) | 2011-02-07 |
BRPI0912545A2 (pt) | 2021-04-13 |
HUE050411T2 (hu) | 2020-12-28 |
HRP20201316T1 (hr) | 2020-11-27 |
CN102118972A (zh) | 2011-07-06 |
SI2913326T1 (sl) | 2020-11-30 |
CN102118972B (zh) | 2015-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2015213309B2 (en) | Novel modulators of sphingosine phosphate receptors | |
KR101582910B1 (ko) | 스핑고신 포스페이트 수용체의 신규한 모듈레이터 | |
PH12015502708B1 (en) | Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis | |
JP7330202B2 (ja) | 化合物およびpde4活性剤としてのそれらの使用 | |
JP2002308882A (ja) | チエノピリミジン誘導体 | |
JPWO2005028453A1 (ja) | フェニル酢酸誘導体、その製造方法および用途 | |
KR20010086355A (ko) | 비트로넥틴 수용체 길항제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
A107 | Divisional application of patent | ||
E701 | Decision to grant or registration of patent right | ||
FPAY | Annual fee payment |
Payment date: 20181129 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20191127 Year of fee payment: 5 |